ARCHIVES

FDA Discloses Responses, Toxicities For Burzynski’s “Antineoplastons”

This article is from The Cancer Letter archive.

Vol. 24 No. 16 | April 24, 1998

Download PDF Visit The Full Archive

Related Articles

Budesonide Not Beneficial For Diarrhea In Melanoma

August 28, 2009

ONS Forms More Special Interest Groups For Members

May 11, 1990

In Brief: McIntyre New AACI President, Salmon President Elect; Hubbard NCI AD; Underleider CIB Chief

September 30, 1988

Five Year Plan for Cancer centers Called ‘East Bloc ’ Directive

February 2, 1990

FDA Concerned About Data-Dredging In Drug-Diagnostic Applications

January 30, 2009

FDA Relies on Importation, Fast Approval, and Early Reporting to Combat Drug Shortages

February 24, 2012